ReviewEuropean radiology2011
European and North American lung cancer screening experience and implications for pulmonary nodule management.
Review in European radiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.
- Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018Guideline
- Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.The Lancet. Oncology · 2016Trial
- Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.Frontiers in medicine · 2025Article
- Comparison of safety and effectiveness of medical adhesive and metal spring coil in preoperative localization of peripheral pulmonary nodules.Frontiers in medicine · 2024Article
- Risk Factors for the Diagnosis of Lung Cancer in Poland: A Large-Scale, Population-Based Case-Control Study.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging.European radiology · 2016Article
- A Comparison of Lung Nodule Segmentation Algorithms: Methods and Results from a Multi-institutional Study.Journal of digital imaging · 2016Article
- Risk factors assessment and risk prediction models in lung cancer screening candidates.Annals of translational medicine · 2016Review
- Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care.JAMA internal medicine · 2014Article
- Demonstration program of population-based lung cancer screening in China: Rationale and study design.Thoracic cancer · 2014Article
- Approach to a solid solitary pulmonary nodule in two different settings-"Common is common, rare is rare".Journal of thoracic disease · 2014Review
- [Advance of lung cancer screening with low-dose spiral CT].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2013Review
- Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT.European radiology · 2013Article
- Inter- and intrascanner variability of pulmonary nodule volumetry on low-dose 64-row CT: an anthropomorphic phantom study.The British journal of radiology · 2013Article
- Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.La Radiologia medica · 2013Review
- Article
- Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study.European radiology · 2013Article
- The role of dynamic magnetic resonance imaging in the evaluation of pulmonary nodules and masses.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2013Article
- Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.Lung · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential for low dose computed tomography (LDCT) to act as an effective tool in screening for lung cancer is currently the subject of several randomised control trials. It has recently been given prominence by interim results released by the North American National Lung Screening Trial (NLST). Several other trials assessing LDCT as a screening tool are currently underway in Europe, and are due to report their final results in the next few years. These include the NELSON, DLSCT, DANTE, ITALUNG, MILD and LUSI trials. Although slow to instigate a trial of its own, the UK Lung Screen (UKLS) trial will shortly commence. The knowledge gained from the newer trials has mostly reinforced and refined previous concepts that have formed the basis of existing nodule management guidelines. This article takes the opportunity to summarise the main aspects and initial results of the trials presently underway, assess the status of current collaborative efforts and the scope for future collaboration, and analyse observations from these studies that may usefully inform the management of the indeterminate pulmonary nodule. Key Points • Low dose CT screening for lung cancer is promising. • The effect of LDCT screening on mortality is still uncertain. • Several European randomised controlled trials for LDCT are underway. • The trials vary in methodology but most compare LDCT to no screening. • Preliminary results have reinforced existing nodule management concepts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.